AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 72 filers reported holding AYTU BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $36,924 | +105.1% | 195,368 | +100.0% | 0.00% | – |
| Q3 2022 | $18,000 | -73.1% | 97,684 | 0.0% | 0.00% | – |
| Q2 2022 | $67,000 | -36.2% | 97,684 | 0.0% | 0.00% | – |
| Q1 2022 | $105,000 | -20.5% | 97,684 | 0.0% | 0.00% | – |
| Q4 2021 | $132,000 | -53.0% | 97,684 | 0.0% | 0.00% | – |
| Q3 2021 | $281,000 | -42.5% | 97,684 | 0.0% | 0.00% | – |
| Q2 2021 | $489,000 | -63.7% | 97,684 | -44.9% | 0.00% | – |
| Q1 2021 | $1,348,000 | +356.9% | 177,311 | +259.9% | 0.00% | – |
| Q4 2020 | $295,000 | – | 49,271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,379,936 | $2,570,000 | 0.05% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 10,880 | $12,000 | 0.00% |
| Renaissance Technologies | 765,469 | $827,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 53,530 | $58,000 | 0.00% |
| Focused Wealth Management, Inc | 209 | $0 | 0.00% |
| FEDERATED HERMES, INC. | 5,633 | $6,000 | 0.00% |
| JANICZEK WEALTH MANAGEMENT, LLC | 1 | $0 | 0.00% |
| UBS Group AG | 1 | $0 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 100 | $0 | 0.00% |
| IFP Advisors, Inc | 2,400 | $16,000 | 0.00% |